CARMAT Share Price Deutsche Boerse AG
Equities
CXT
FR0010907956
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.835 EUR | -5.66% | -5.18% | -58.12% |
21/05 | CARMAT : Invest Securities remains Buy, lowers its target | CF |
17/05 | Oddo BHF Cuts Carmat PT, Affirms Neutral Rating | MT |
Sales 2024 * | 20.98M 22.52M 1.88B | Sales 2025 * | 43.62M 46.83M 3.91B | Capitalization | 100M 108M 9B |
---|---|---|---|---|---|
Net income 2024 * | -39M -41.87M -3.5B | Net income 2025 * | -30M -32.21M -2.69B | EV / Sales 2024 * | 7.84 x |
Net Debt 2024 * | 64.27M 69M 5.77B | Net Debt 2025 * | 106M 113M 9.47B | EV / Sales 2025 * | 4.72 x |
P/E ratio 2024 * |
-2.12
x | P/E ratio 2025 * |
-2.95
x | Employees | 182 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.51% |
Latest transcript on CARMAT
1 day | -5.66% | ||
1 week | -5.18% | ||
Current month | -7.95% | ||
1 month | -32.82% | ||
3 months | -29.74% | ||
6 months | -50.09% | ||
Current year | -58.12% |
Managers | Title | Age | Since |
---|---|---|---|
Stéphane Piat
CEO | Chief Executive Officer | 53 | 01/16/01 |
Director of Finance/CFO | - | 12/18/12 | |
Marc Grimmé
CTO | Chief Tech/Sci/R&D Officer | - | 25/08/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alexandre Conroy
CHM | Chairman | 61 | 22/22/22 |
Pierre Bastid
BRD | Director/Board Member | 69 | 05/18/05 |
Director/Board Member | 61 | 07/21/07 |
Date | Price | Change |
---|---|---|
13/24/13 | 2.835 | -5.66% |
12/24/12 | 3.005 | +4.16% |
11/24/11 | 2.885 | -1.70% |
10/24/10 | 2.935 | -2.33% |
07/24/07 | 3.005 | +0.50% |
Delayed Quote Deutsche Boerse AG, June 13, 2024 at 08:50 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.55% | 131B | |
-6.26% | 11.25B | |
-10.14% | 7.84B | |
+42.95% | 5.72B | |
-17.77% | 4.97B | |
+8.21% | 3.44B | |
-19.83% | 2.46B | |
-13.82% | 2.02B | |
-15.84% | 1.87B |
- Stock Market
- Equities
- ALCAR Stock
- CXT Stock